Instead of stopping COVID-19, Merck’s Lagevrio drug may actually help mutate the virus, according to a new, non-peer reviewed study. Merck, meanwhile, denies the accuracy of the study. Researchers from the U.S. and the U.K., including the Francis Crick Institute and Imperial College London say that …